142 related articles for article (PubMed ID: 36420570)
61. Current and future strategies in radiotherapy for small-cell lung cancer.
de Dios NR; Murcia-Mejía M
J Clin Transl Res; 2020 Oct; 6(4):97-108. PubMed ID: 33521370
[TBL] [Abstract][Full Text] [Related]
62. Durvalumab: A Review in Extensive-Stage SCLC.
Al-Salama ZT
Target Oncol; 2021 Nov; 16(6):857-864. PubMed ID: 34731446
[TBL] [Abstract][Full Text] [Related]
63. The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts.
Putora PM; De Ruysscher D; Glatzer M; Widder J; Van Houtte P; Troost EGC; Slotman BJ; Ramella S; Pöttgen C; Peeters S; Nestle U; McDonald F; Le Pechoux C; Dziadziuszko R; Belderbos J; Faivre-Finn C
Radiother Oncol; 2020 Apr; 145():45-48. PubMed ID: 31887577
[TBL] [Abstract][Full Text] [Related]
64. Update 2021: Management of Small Cell Lung Cancer.
Tariq S; Kim SY; Monteiro de Oliveira Novaes J; Cheng H
Lung; 2021 Dec; 199(6):579-587. PubMed ID: 34757446
[TBL] [Abstract][Full Text] [Related]
65. Role of thoracic radiation in extensive stage small cell lung cancer: a NCDB analysis.
Komiya T; Powell E; Takamori S
Med Oncol; 2021 Mar; 38(4):44. PubMed ID: 33742288
[TBL] [Abstract][Full Text] [Related]
66. Radiochemotherapy in extensive disease small cell lung cancer ED-SCLC.
Jeremic B; Casas F; Wang L; Perin B
Front Radiat Ther Oncol; 2010; 42():180-186. PubMed ID: 19955805
[TBL] [Abstract][Full Text] [Related]
67. Current status and future perspectives of immune checkpoint inhibitors in extensive-stage small cell lung cancer.
Liu X; Xing H; Liu B
Am J Cancer Res; 2022; 12(6):2447-2464. PubMed ID: 35812062
[TBL] [Abstract][Full Text] [Related]
68. Prognostic factor analysis of patients with small cell lung cancer: Real-world data from 988 patients.
Ma X; Zhang Z; Chen X; Zhang J; Nie J; Da L; Hu W; Tian G; Wu D; Han J; Han S; Long J; Wang Y; Fang J
Thorac Cancer; 2021 Jun; 12(12):1841-1850. PubMed ID: 33955685
[TBL] [Abstract][Full Text] [Related]
69. Is prophylactic cranial irradiation indicated for patients with extensive-stage small cell lung cancer with a complete response to first-line treatment?
Suzuki R; Komaki R
Radiother Oncol; 2018 Jun; 127(3):339-343. PubMed ID: 29747874
[TBL] [Abstract][Full Text] [Related]
70. Abscopal effect of radiation therapy and nivolumab in a patient with combined small-cell lung cancer: a case report.
Wang W; Li L; Wu S; Shen J; Huang C; Chen Y; Li S
Immunotherapy; 2022 Aug; 14(12):909-914. PubMed ID: 35787148
[TBL] [Abstract][Full Text] [Related]
71. Practice Patterns of Thoracic Radiotherapy for Extensive-Stage Small-Cell Lung Cancer: Survey of US Academic Thoracic Radiation Oncologists.
Post CM; Verma V; Mitin T; Simone CB
Clin Lung Cancer; 2017 May; 18(3):310-315.e1. PubMed ID: 28087132
[TBL] [Abstract][Full Text] [Related]
72. Role of prophylactic cranial irradiation for elderly patients with limited-disease small-cell lung cancer: inverse probability of treatment weighting using propensity score.
Kim TG; Pyo H; Ahn YC; Noh JM; Oh D
J Radiat Res; 2019 Oct; 60(5):630-638. PubMed ID: 31165148
[TBL] [Abstract][Full Text] [Related]
73. Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease - a randomized, open-label, multicenter phase II trial.
Bozorgmehr F; Christopoulos P; Chung I; Cvetkovic J; Feißt M; Krisam J; Schneider MA; Heußel CP; Kreuter M; Müller DW; Thomas M; Rieken S
BMC Cancer; 2022 Sep; 22(1):1011. PubMed ID: 36153496
[TBL] [Abstract][Full Text] [Related]
74. Current Diagnosis and Management of Small-Cell Lung Cancer.
Wang S; Zimmermann S; Parikh K; Mansfield AS; Adjei AA
Mayo Clin Proc; 2019 Aug; 94(8):1599-1622. PubMed ID: 31378235
[TBL] [Abstract][Full Text] [Related]
75. [Effects of Local Radiation Combined with Chemotherapy in the treatment of
Patients with Extensive-stage Small Cell Lung Cancer].
Wu D; Fang J; Nie J; Dai L; Chen X; Zhang J; Hu W; Han J; Ma X; Tian G; Han S; Long J; Wang Y
Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):272-9. PubMed ID: 25975297
[TBL] [Abstract][Full Text] [Related]
76. Re-evaluation of prophylactic cranial irradiation in limited-stage small cell lung cancer: a propensity score matched analysis.
Inoue Y; Tsujino K; Sulaiman NS; Marudai M; Kajihara A; Miyazaki S; Sekii S; Uezono H; Ota Y; Soejima T
J Radiat Res; 2021 Sep; 62(5):877-883. PubMed ID: 34230962
[TBL] [Abstract][Full Text] [Related]
77. Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer.
Halvorsen TO; Sundstrøm S; Fløtten Ø; Brustugun OT; Brunsvig P; Aasebø U; Bremnes RM; Kaasa S; Grønberg BH
Acta Oncol; 2016 Nov; 55(11):1349-1354. PubMed ID: 27549509
[TBL] [Abstract][Full Text] [Related]
78. Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis.
Zayed S; Chen H; Ali E; Rodrigues GB; Warner A; Palma DA; Louie AV
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):575-586. PubMed ID: 32544575
[TBL] [Abstract][Full Text] [Related]
79. Thoracic radiation therapy could give survival benefit to elderly patients with extensive-stage small-cell lung cancer.
An C; Jing W; Zhang Y; Liu S; Wang H; Zhu K; Kong L; Guo H; Zhu H
Future Oncol; 2017 Jun; 13(13):1149-1158. PubMed ID: 28326834
[TBL] [Abstract][Full Text] [Related]
80. American Radium Society Appropriate Use Criteria: Radiation Therapy for Limited-Stage SCLC 2020.
Chun SG; Simone CB; Amini A; Chetty IJ; Donington J; Edelman MJ; Higgins KA; Kestin LL; Movsas B; Rodrigues GB; Rosenzweig KE; Slotman BJ; Rybkin II; Wolf A; Chang JY
J Thorac Oncol; 2021 Jan; 16(1):66-75. PubMed ID: 33166720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
